(Total Views: 286)
Posted On: 03/03/2020 4:44:01 PM
Post# of 36566
Here is my question then for you. What would you say about the PR that was put out last week that stated they would have the S-1 in this week?
The S-1 I am referring to by the way, is for the NGIO.
Mr. Moscato continued, “With the dividend being paid next week, and our Generex S-1 registration statement filed, we can now execute fully on our plans. As a first step next week, we will be filing an S-1 for the spin out of NuGenerex Immuno-Oncology, with goal of listing directly onto the Nasdaq. With the S-1 funding, our subsidiaries can increase manufacturing, sales & marketing, and distribution of our revenue generating products
The S-1 I am referring to by the way, is for the NGIO.
Mr. Moscato continued, “With the dividend being paid next week, and our Generex S-1 registration statement filed, we can now execute fully on our plans. As a first step next week, we will be filing an S-1 for the spin out of NuGenerex Immuno-Oncology, with goal of listing directly onto the Nasdaq. With the S-1 funding, our subsidiaries can increase manufacturing, sales & marketing, and distribution of our revenue generating products
(0)
(0)
